Sleep-Disordered Breathing and Nocturnal Hypoxemia in Precapillary Pulmonary Hypertension: Prevalence, Pathophysiological Determinants, and Clinical Consequences.


Journal

Respiration; international review of thoracic diseases
ISSN: 1423-0356
Titre abrégé: Respiration
Pays: Switzerland
ID NLM: 0137356

Informations de publication

Date de publication:
Historique:
received: 18 11 2020
accepted: 22 02 2021
pubmed: 29 4 2021
medline: 17 5 2022
entrez: 28 4 2021
Statut: ppublish

Résumé

The clinical relevance and interrelation of sleep-disordered breathing and nocturnal hypoxemia in patients with precapillary pulmonary hypertension (PH) is not fully understood. Seventy-one patients with PH (age 63 ± 15 years, 41% male) and 35 matched controls were enrolled. Patients with PH underwent clinical examination with assessment of sleep quality, daytime sleepiness, 6-minute walk distance (6MWD), overnight cardiorespiratory polygraphy, lung function, hypercapnic ventilatory response (HCVR; by rebreathing technique), amino-terminal pro-brain natriuretic peptide (NT-proBNP) levels, and cardiac MRI (n = 34). Prevalence of obstructive sleep apnea (OSA) was 68% in patients with PH (34% mild, apnea-hypopnea index [AHI] ≥5 to <15/h; 34% moderate to severe, AHI ≥15/h) versus 5% in controls (p < 0.01). Only 1 patient with PH showed predominant central sleep apnea (CSA). Nocturnal hypoxemia (mean oxygen saturation [SpO2] <90%) was present in 48% of patients with PH, independent of the presence of OSA. There were no significant differences in mean nocturnal SpO2, self-reported sleep quality, 6MWD, HCVR, and lung and cardiac function between patients with moderate to severe OSA and those with mild or no OSA (all p > 0.05). Right ventricular (RV) end-diastolic (r = -0.39; p = 0.03) and end-systolic (r = -0.36; p = 0.04) volumes were inversely correlated with mean nocturnal SpO2 but not with measures of OSA severity or daytime clinical variables. OSA, but not CSA, is highly prevalent in patients with PH, and OSA severity is not associated with nighttime SpO2, clinical and functional status. Nocturnal hypoxemia is a frequent finding and (in contrast to OSA) relates to structural RV remodeling in PH.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
The clinical relevance and interrelation of sleep-disordered breathing and nocturnal hypoxemia in patients with precapillary pulmonary hypertension (PH) is not fully understood.
METHODS METHODS
Seventy-one patients with PH (age 63 ± 15 years, 41% male) and 35 matched controls were enrolled. Patients with PH underwent clinical examination with assessment of sleep quality, daytime sleepiness, 6-minute walk distance (6MWD), overnight cardiorespiratory polygraphy, lung function, hypercapnic ventilatory response (HCVR; by rebreathing technique), amino-terminal pro-brain natriuretic peptide (NT-proBNP) levels, and cardiac MRI (n = 34).
RESULTS RESULTS
Prevalence of obstructive sleep apnea (OSA) was 68% in patients with PH (34% mild, apnea-hypopnea index [AHI] ≥5 to <15/h; 34% moderate to severe, AHI ≥15/h) versus 5% in controls (p < 0.01). Only 1 patient with PH showed predominant central sleep apnea (CSA). Nocturnal hypoxemia (mean oxygen saturation [SpO2] <90%) was present in 48% of patients with PH, independent of the presence of OSA. There were no significant differences in mean nocturnal SpO2, self-reported sleep quality, 6MWD, HCVR, and lung and cardiac function between patients with moderate to severe OSA and those with mild or no OSA (all p > 0.05). Right ventricular (RV) end-diastolic (r = -0.39; p = 0.03) and end-systolic (r = -0.36; p = 0.04) volumes were inversely correlated with mean nocturnal SpO2 but not with measures of OSA severity or daytime clinical variables.
CONCLUSION CONCLUSIONS
OSA, but not CSA, is highly prevalent in patients with PH, and OSA severity is not associated with nighttime SpO2, clinical and functional status. Nocturnal hypoxemia is a frequent finding and (in contrast to OSA) relates to structural RV remodeling in PH.

Identifiants

pubmed: 33910200
pii: 000515602
doi: 10.1159/000515602
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

865-876

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Jens Spiesshoefer (J)

Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany.
Department of Neurology with Institute for Translational Neurology, University Hospital Muenster, Münster, Germany.
Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.

Simon Herkenrath (S)

Bethanien Hospital Solingen, Solingen, Germany.
Institute for Pneumology at the University of Cologne, Solingen, Germany.

Katharina Harre (K)

Department of Neurology with Institute for Translational Neurology, University Hospital Muenster, Münster, Germany.

Florian Kahles (F)

Department of Cardiology, Vascular Medicine and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany.

Anca Florian (A)

Department of Cardiology I, University Hospital Muenster, Münster, Germany.

Ali Yilmaz (A)

Department of Cardiology I, University Hospital Muenster, Münster, Germany.

Michael Mohr (M)

Department of Medicine A, Hematology, Oncology and Pulmonary Medicine, University Hospital Muenster, Münster, Germany.

Matthew Naughton (M)

Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.
Department of Medicine, Monash University, Melbourne, Victoria, Australia.

Winfried Randerath (W)

Bethanien Hospital Solingen, Solingen, Germany.
Institute for Pneumology at the University of Cologne, Solingen, Germany.

Michele Emdin (M)

Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, CNR-Regione Toscana, Pisa, Italy.

Claudio Passino (C)

Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, CNR-Regione Toscana, Pisa, Italy.

Binaya Regmi (B)

Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany.

Michael Dreher (M)

Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany.

Matthias Boentert (M)

Department of Neurology with Institute for Translational Neurology, University Hospital Muenster, Münster, Germany.
Department of Medicine, UKM Marienhospital Steinfurt, Steinfurt, Germany.

Alberto Giannoni (A)

Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, CNR-Regione Toscana, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH